AzTrials
AzTrials

Smoking Cessation; Tobacco DependenceNCT06901713

Smoking Cessation Program With CBT and Mindfulness Audio Support: A Randomized Controlled Trial

A study testing cognitive behaviour thearpy and mindfulness in people with Smoking Cessation; Tobacco Dependence, run by Sir Run Run Shaw Hospital at 1 site in China.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

This protocol describes a randomized controlled trial evaluating the effectiveness of a smoking cessation program with two intervention methods. One method provides only CBT text messages (Group A), while the other combines CBT text with mindfulness audio (Group B). Read more about this study

Who is it for?
Ages 18 to 65 years
Conditions the study is for
Smoking Cessation; Tobacco Dependence
What is being tested?
cognitive behaviour thearpy and mindfulness
Could I receive a placebo?
No, everyone receives an active treatment
How many people
2,000 participants
Where
1 siteChina
Study dates
9 Oct 2024to 1 Nov 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Who smoke at least 5 cigarettes per day.
  • Express a desire to quit or reduce smoking.
  • Who has the ability to access and use the provided digital materials.

Who cannot join

  • Those currently enrolled in other smoking cessation programs.
  • Individuals with severe psychiatric disorders that may interfere with participation.
  • Those without access to the necessary digital devices.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

China1 site, 1 recruiting
  • Sir Run Run Shaw Hospital

    Hangzhou

    Yanhui Liao, +86 18814898844, liaoyanhui@zju.edu.cn

    Recruiting

Other trials in China

About this study

Official title: Protocol for a Smoking Cessation Program With CBT Text and Mindfulness Audio Support: A Randomized Controlled Trial

This protocol describes a randomized controlled trial evaluating the effectiveness of a smoking cessation program with two intervention methods. One method provides only CBT text messages (Group A), while the other combines CBT text with mindfulness audio (Group B). The study aims to compare the two approaches in reducing smoking frequency, managing cravings, and improving emotional regulation.

This study investigates the effects of two different smoking cessation interventions: (1) CBT text-based program alone (Group A), and (2) CBT text combined with mindfulness audio (Group B). The primary outcomes include reductions in smoking frequency and cravings, as well as improvements in emotional regulation and quality of life.

Read the detailed description

Design: A randomized controlled trial (RCT) will be used to compare the outcomes of the two intervention groups.

Setting: The study will be conducted online. Participants will access the CBT text materials through a dedicated platform and the mindfulness audio via a compatible device. Recruitment will be done through social media, community outreach, and online advertisements.

Being tested
cognitive behaviour thearpy, mindfulness
Medical subject headings
Smoking Cessation, Tobacco Use Disorder

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • cognitive behaviour thearpyOther

    Participants will access the CBT text materials through a dedicated platform

  • mindfulnessOther

    Participants will access the mindfulness audio via a compatible device

Study groups in NCT06901713
Study groupRoleWhat they receive
CBT text-based program aloneActive comparatorParticipants in this group will receive CBT text messages focused on smoking cessation strategies, including identifying triggers, developing coping mechanisms, and setting goals. These messages will be sent at regular intervals over the course of the 8-week program.
Receives: Other: cognitive behaviour thearpy
CBT text combined with mindfulness audioExperimentalIn addition to the CBT text messages similar to Group A, participants in this group will also have access to a series of mindfulness audio recordings. These recordings will guide participants through mindfulness exercises such as body scans, breath awareness, and meditation, designed to enhance self-awareness and emotion regulation in the context of smoking cessation. The audio will be provided weekly, corresponding to the weekly themes of the program. Participants in this group will receive emotional support and peer-related information from chatbots.
Receives: Other: cognitive behaviour thearpy; Other: mindfulness

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Biological Verification of Abstinence

    Confirmation of smoking abstinence at the end of the study period using cotinine test strips. This will be the main measure to assess the effectiveness of the smoking cessation interventions.

    Measured: 6 Months

Secondary outcomes (3)
  1. Smoking Frequency

    Measured by the number of cigarettes smoked per day at baseline

    Measured: Baseline, Week 4, Week 8, Week 12, Week 16, Week 20, and Week 26.

  2. Craving Intensity

    Assessed using a visual analog scale (VAS)

    Measured: Baseline, Week 4, Week 8, Week 12, Week 16, Week 20, and Week 26.

  3. Emotional Regulation

    Evaluated using the Depression, Anxiety, and Stress Scale (DASS-21)

    Measured: Baseline, Week 12, and Week 26

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted30 Mar 2025
  2. Study start9 Oct 2024
  3. Primary completion1 Nov 2026 (estimated)
  4. Study completion1 Nov 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
2,000 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06901713
Sponsor's protocol ID
2024-2068-01
Status last verified
Feb 2025
First submitted
24 Mar 2025
Last updated
24 Apr 2025
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Li S, Meng L, Chiolero A, Ma C, Xi B. Trends in smoking prevalence and attributable mortality in China, 1991-2011. Prev Med. 2016 Dec;93:82-87. doi: 10.1016/j.ypmed.2016.09.027. Epub 2016 Sep 24.

    PubMed 27677441
  • Li Q, Hsia J, Yang G. Prevalence of smoking in China in 2010. N Engl J Med. 2011 Jun 23;364(25):2469-70. doi: 10.1056/NEJMc1102459. No abstract available.

    PubMed 21696322
  • Chen R, Ye R, Liao Y. Smoking cessation with CBT and mindfulness: study protocol for a randomized controlled trial. Trials. 2026 Mar 19;27(1):325. doi: 10.1186/s13063-026-09611-9.

    PubMed 41857743

Questions about this trial

What is this clinical trial studying?

A study testing cognitive behaviour thearpy and mindfulness in people with Smoking Cessation; Tobacco Dependence, run by Sir Run Run Shaw Hospital at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 24 Apr 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Yanhui Liao (86 18814898844, liaoyanhui@zju.edu.cn), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Biological Verification of Abstinence (time frame: 6 Months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06901713, which also lists 3 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 24 Apr 2025.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in